Search Results

TAVR and SAVR Durability: When Will We Have the Answer?

Reviewing the recent data on structural valve deterioration and bioprosthetic valve failure after TAVR and SAVR.

By Ole De Backer, MD, PhD; Ivan Wong, MD; and Lars Søndergaard, MD, DMSc

Contemporary Issues in TAVR

By James McCabe, MD, and Darren Mylotte, MD

Current Approach to Slow Flow and No-Reflow

A preventive approach appears to be the best strategy based on current understanding of this phenomenon.

By Sandhir Prasad, MBBS, FRACP, and Ian T. Meredith, MBBS, PhD, FRACP, FACC, FSCAI

Ask the Experts: Is Patent Hemostasis After Radial Access Truly Valuable?

With Ian C. Gilchrist, MD, FSCAI; Kimberly Skelding, MD, FACC, FAHA, FSCAI; and Jennifer A. Tremmel, MD, MS

Acute Right Ventricular Failure

A review of diagnosis and principles of percutaneous mechanical circulatory support to optimize RV preload, afterload, and contractility after acute RV failure.

By Ivan D. Hanson, MD, and James A. Goldstein, MD

Transcatheter Edge-to-Edge Repair in Acute Decompensated Heart Failure

The feasibility of TEER for managing patients with severe mitral regurgitation in acute decompensated heart failure or cardiogenic shock.

By Ningyan Wong, MBBS; Nishtha Sodhi, MD; and D. Scott Lim, MD

Clinical Implications and Treatment of Coronary Microvascular Obstruction in STEMI

The unmet need of effectively targeting MVO to improve clinical outcomes.

By Rocco A. Montone, MD, PhD, and Filippo Crea, MD, PhD, FESC, FACC

Is FFR of the Left Main Coronary Artery Stenosis Reliable?

Understanding the technique and limitations of its applications.

By Morton J. Kern, MD, MSCAI, FAHA, FACC

Assessing Intermediate Left Main Lesions With IVUS or FFR

How intravascular ultrasound and fractional flow reserve can be used in this challenging subset.

By Juzar Lokhandwala, MD, and John McB Hodgson, MD, FACC, FSCAI

TAVR Using CoreValve

World experience and an update of the United States pivotal trial.

By Peter S. Fail, MD, FACC, FACP; Edgar Feinberg, MD, FACS; and Gary Chaisson, RTR, RICA

Physiologic Lesion Assessment

Fractional flow reserve has become an indispensable tool in guiding the decision for PCI in intermediate lesions and likely improves outcomes in patients undergoing multivessel PCI.

By William F. Fearon, MD

Current Catheter-Based Treatments of Functional Mitral Regurgitation

Percutaneous approaches for managing mitral valve disease.

By Jeffrey A. Southard, MD, and Jason H. Rogers, MD

Role of Multivessel Intervention in Diabetes Mellitus

Advances in interventional procedures and medical therapy offer promising treatment options for the diabetic patient population.

By Sameer Bansilal, MD, MS; Samin Sharma, MD; and Michael Farkouh, MD, MScr

Update on FFR, OCT, and IVUS

Expanded use of these modalities could overcome the limitations of coronary angiography.

By Konstantinos Marmagkiolis, MD, MBA, FACC, FSCAI; Massoud Leesar, MD, FACC, FSCAI; and Mehmet Cilingiroglu, MD, FSCAI, FACC, FESC, FAHA

Update on Left Atrial Appendage Occlusion

An overview of innovative preprocedural and intraprocedural imaging techniques, trial data, and current LAAO devices and devices in development.

By Saurabh Sanon, MD, and D. Scott Lim, MD

Defining Left Main Stenosis Severity With IVUS and FFR

Two complementary modalities provide doctors with data on when to intervene.

By Filippo Figini, MD, and Azeem Latib, MD, FACC

Evaluating Left Main Severity

Making the case for IVUS as a valuable imaging modality in addition to angiography.

By Rodrigo Bagur, MD, and Sté,phane Rinfret, MD, SM, FRCP(C)

Using Fractional Flow Reserve in Complex Lesions

FFR overcomes other technologies' shortcomings to fine-tune clinical decisions for challenging cases.

By Mouhamad H. Abdallah, MD; Carlos Sanchez, MD; and Massoud A. Leesar, MD, FACC, FSCAI